Kampala, Uganda | URN | African scientists are urging governments across the continent to take greater ownership of HIV cure research, saying Africa must move beyond serving as a testing ground for scientific breakthroughs and become a global leader in developing an HIV cure. The call was made during the 2026 …
Read More »STUDY: HIV injectable drug offers pregnant, lactating mothers 100% protection
SPECIAL REPORT | URN | A sub-study of the landmark clinical trial evaluating the safety and efficacy of the twice-yearly injectable HIV prevention drug, Lenacapavir, has found that it provides 100 percent protection against HIV infection among pregnant and breastfeeding women using it as pre-exposure prophylaxis (PrEP). The Phase 3 …
Read More »Experts urge caution over HIV prevention injection
Kampala, Uganda | URN | Experts have urged those who already received their first injection of the twice-yearly HIV preventing drug Lenacapavir to consider using combination prevention options, warning that the game changer injection is not a vaccine. The initial recipients of the drug that has since had a lot …
Read More »Quality Chemicals joins global push for new HIV prevention medicine
The pharmaceutical company is among a select group of manufacturers preparing to produce an experimental once-monthly pill aimed at expanding HIV prevention options Kampala, Uganda | THE INDEPENDENT | Uganda’s Quality Chemical Industries Ltd. (QCIL) has secured an early manufacturing licence from Merck & Co. for an experimental …
Read More »HIV science races ahead as funding crisis threatens to widen access gap
People living with HIV need new treatment options that offer flexibility, and a weekly pill could broaden the choices available Kampala, Uganda | PATRICIA AKANKWATSA | For more than two decades, scientific innovation and international financing have worked together to transform HIV from a deadly disease into a …
Read More »Scientists study yearly HIV prevention injection possibility
Kampala, Uganda | URN | Scientists are exploring the possibility of having the popular HIV prevention injection Lenacapavir in a formulation dispensed once a year. The drug, first approved in 2025 and whose uptake is reported to be high in Uganda as a twice-yearly Pre-Exposure Prophylaxis (PrEP), according to Senior …
Read More »HIV integration must not come at the cost of access, experts warn
According to the World Health Organization, the African region remains home to nearly two-thirds of all people living with HIV globally Kampala, Uganda | PATRICIA AKANKWATSA | As Uganda and other African countries seek to integrate HIV prevention into mainstream health systems, experts are warning that the shift …
Read More »HIV jab demand outstrips supply in African rollout
Uganda and Kenya are among nine African countries to have received initial doses of the HIV drug Nairobi, Kenya | AGENCIES | Demand for a twice-yearly HIV prevention injection is outpacing supply in parts of Africa, with distribution covering a fraction of estimated need and leaving behind vulnerable slum communities, according to health …
Read More »One in three young African women have never tested for HIV
New study shows where the gaps lie COMMENT | OBASANJO BOLARINWA & SYLVESTER OKEKE | HIV remains one of the biggest public health challenges in sub-Saharan Africa, a region that accounts for approximately two-thirds of about 40 million people living with HIV globally. Young people continue to account …
Read More »Botswana’s Ex-President Festus Mogae, who tackled H.I.V., Dies at 86
The democrat was considered the architect of the Southern African country’s economic rise and a pioneer in the fight against AIDS Gaborone, Botswana | AGENCIES | The political career of Botswana’s ex-President Festus Gontebanye Mogae can be summarized under one heading: “good governance.” During his time in office from 1998 …
Read More »
The Independent Uganda: You get the Truth we Pay the Price